GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Additional Paid-In Capital

EZZ Life Science Holdings (ASX:EZZ) Additional Paid-In Capital : A$0.00 Mil(As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Additional Paid-In Capital?



EZZ Life Science Holdings Additional Paid-In Capital Historical Data

The historical data trend for EZZ Life Science Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Additional Paid-In Capital Chart

EZZ Life Science Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Additional Paid-In Capital
- - - -

EZZ Life Science Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial - - - - -

EZZ Life Science Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

EZZ Life Science Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


EZZ Life Science Holdings (ASX:EZZ) Business Description

Traded in Other Exchanges
N/A
Address
104 Derby Street, Silverwater, NSW, AUS, 2128
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines